Embed this press release by copying the code below:
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) Long Term Investor Notice: Investigation of Potential Wrongdoing
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) Long Term Investor Notice: Investigation of Potential Wrongdoing